189 results match your criteria: "Rwanda Biomedical centre[Affiliation]"
Nat Microbiol
April 2021
Division of Infection and Immunity, Cardiff University, Cardiff, UK.
Lancet Glob Health
June 2021
Discipline of Pharmaceutical Sciences, School of Health Sciences, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.
BMC Infect Dis
February 2021
Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Background: To eliminate hepatitis C, Rwanda is conducting national mass screenings and providing to people with chronic hepatitis C free access to Direct Acting Antivirals (DAAs). Until 2020, prescribers trained and authorized to initiate DAA treatment were based at district hospitals, and access to DAAs remains expensive and geographically difficult for rural patients. We implemented a mobile clinic to provide DAA treatment initiation at primary-level health facilities among people with chronic hepatitis C identified through mass screening campaigns in rural Kirehe and Kayonza districts.
View Article and Find Full Text PDFOpen Forum Infect Dis
February 2021
Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Trans R Soc Trop Med Hyg
December 2020
Centre for Global Health Research, Brighton & Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9PX, UK.
Background: Podoconiosis is a progressive swelling of the legs affecting genetically susceptible people who live in areas with irritant red clay soils and walk barefoot. The disease is a public health concern in many countries, including Rwanda.
Methods: This retrospective study described individual and familial characteristics of patients with podoconiosis attending the Heart and Sole Africa (HASA) clinics in Rwanda.
Suppressing infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will probably require the rapid identification and isolation of individuals infected with the virus on an ongoing basis. Reverse-transcription polymerase chain reaction (RT-PCR) tests are accurate but costly, which makes the regular testing of every individual expensive. These costs are a challenge for all countries around the world, but particularly for low-to-middle-income countries.
View Article and Find Full Text PDFBMC Pregnancy Childbirth
October 2020
Jhpiego Corporation, 1615 Thames St., Baltimore, MD, USA.
Background: Helping Babies Breathe (HBB) is a competency-based educational method for an evidence-based protocol to manage birth asphyxia in low resource settings. HBB has been shown to improve health worker skills and neonatal outcomes, but studies have documented problems with skills retention and little evidence of effectiveness at large scale in routine practice. This study examined the effect of complementing provider training with clinical mentorship and quality improvement as outlined in the second edition HBB materials.
View Article and Find Full Text PDFLancet Microbe
October 2020
Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Nat Med
October 2020
Malaria Genetics and Resistance Unit-Institut Pasteur, INSERM U1201, CNRS ERL9195, Paris, France.
Am J Trop Med Hyg
October 2020
2Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
We report a case of acquired fluoroquinolone (FQ) resistance under short-course multidrug-resistant tuberculosis (MDR-TB) treatment. The patient was managed at Kabutare hospital, one of the two specialized MDR-TB clinics in Rwanda. A low dose of moxifloxacin was used in the first three critical months.
View Article and Find Full Text PDFStud Health Technol Inform
June 2020
University of Rwanda, Center for Biomedical Engineering and ehealth, Rwanda.
Lancet Microbe
June 2020
Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
World J Surg
September 2020
Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
PLoS One
July 2020
KNCV Tuberculosis Foundation, The Hague, the Netherlands.
Background: Rwanda conducted a national tuberculosis (TB) prevalence survey to determine the magnitude of TB in the country and determine to what extent the national surveillance system captures all TB cases. In addition we measured the patient diagnostic rate, comparing the measured TB burden data with the routine surveillance data to gain insight into how well key population groups are being detected.
Methods: A national representative nationwide cross-sectional survey was conducted in 73 clusters in 2012 whereby all enrolled participants (residents aged 15 years and above) were systematically screened for TB by symptoms and chest X-ray (CXR).
Int J Tuberc Lung Dis
March 2020
Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp.
In 2005, in response to the increasing prevalence of rifampicin-resistant tuberculosis (RR-TB) and poor treatment outcomes, Rwanda initiated the programmatic management of RR-TB, including expanded access to systematic rifampicin drug susceptibility testing (DST) and standardised treatment. To describe trends in diagnostic and treatment delays and estimate their effect on RR-TB mortality. Retrospective analysis of individual-level data including 748 (85.
View Article and Find Full Text PDFCell Mol Biol (Noisy-le-grand)
December 2019
Center for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
The aim of the present study was to examine characteristics of tuberculosis (TB) patients with different clinical forms and to study the frequency of Regulatory T cells (Treg cells) and Activated T cells in patients with new active and relapse TB. Forty-five pulmonary TB patients and a control group of 15 healthy individuals were enrolled in this study. Of the 45 TB patients, 15 were new cases with drug-susceptible active TB and 30 were relapsed cases (15 drug-susceptible and 15 multidrug resistant-TB).
View Article and Find Full Text PDFBMC Psychol
December 2019
Mental Health Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Background: The 1994 Genocide against the Tutsi was a major traumatic event affecting nearly all Rwandans. Significant psychological sequels continue to occur in the population 25 years after, with a high prevalence of posttraumatic stress disorder (PTSD) found in women. Three groups are typically designated with regard to the Genocide against the Tutsi: those who were targeted and categorized as genocide "survivors," those who were in the country during the genocide and were the "non-targeted" group, and those who were outside of the country, referred to as the "1959 returnees.
View Article and Find Full Text PDFJ Glob Oncol
November 2019
Ministry of Health, Kigali, Rwanda.
Purpose: Feasible and effective strategies are needed to facilitate earlier diagnosis of breast cancer in low-income countries. The goal of this study was to examine the impact of health worker breast health training on health care utilization, patient diagnoses, and cancer stage in a rural Rwandan district.
Methods: We conducted a cluster randomized trial of a training intervention at 12 of the 19 health centers (HCs) in Burera District, Rwanda, in 2 phases.
Vector Borne Zoonotic Dis
October 2019
Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Chikungunya virus (CHIKV) and West Nile virus (WNV) have previously been reported from several African countries, including those bordering Rwanda where they may have originated. However, there have been no serosurveillance reports from Rwanda regarding these two viral pathogens. In this article, we present the first study of immunoglobulin G (IgG) seroreactivity of CHIKV and WNV in Rwandan blood donor samples.
View Article and Find Full Text PDFInt J Cancer
March 2020
International Agency for Research on Cancer, Lyon, France.
The study aim was to describe human papillomavirus (HPV)-attributable cancer burden in Rwanda, according to anogenital cancer site, HPV type, age and HIV status. Tissue specimens of cervical, vulvar, vaginal, penile and anal cancer diagnosed in 2012-2018 were retrieved from three cancer referral hospitals and tested for high-risk (HR) HPV DNA. Cervical cancer represented the majority of cases (598 of 738), of which 96.
View Article and Find Full Text PDFTrop Med Int Health
July 2019
Tuberculosis and Other Respiratory Diseases Division, Rwanda Biomedical Centre, Kigali, Rwanda.
Objective: To determine prevalent MDR-TB genotypes and describe treatment outcome and bacteriology conversion in MDR-TB patients.
Methods: Review of laboratory records of 173 MDR-TB patients from all over Rwanda who initiated treatment under programmatic management of MDR-TB (PMDT) between 2014 and 2015. Fifty available archived isolates were genotyped by mycobacterial interspersed repetitive units - variable number of tandem repeats (MIRU-VNTR) genotyping.
BMC Infect Dis
April 2019
Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Spitalstrasse 12, 1st floor, CH-4031, Basel, Switzerland.
Background: Currently, there is limited evidence on the effectiveness of second-line antiretroviral therapy (ART) in sub-Saharan Africa. To address this challenge, outcomes of second-line protease inhibitor (PI) based ART in Rwanda were assessed.
Methods: A two-stage cluster sampling design was undertaken.
AAS Open Res
February 2019
Institute of Immunology & Infection Research, University of Edinburgh, Edinburgh, UK.
Schistosomiasis is prevalent in many sub-Saharan African countries and transmission is through waters contaminated by infected snails. In Rwanda, although schistosomiasis is endemic, very few epidemiological studies exist; of these, schoolchildren have been the focus, neglecting pre-school-aged children (PSAC). Furthermore, malacological surveys to indicate the potential for transmission are scarce in the country.
View Article and Find Full Text PDFBMC Infect Dis
January 2019
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Background: To achieve the ambitious 90-90-90 UNAIDS targets, access to routine viral load (VL) is critical. To measure VL, Rwanda has relied on a national reference laboratory for years. In 2014, a VL testing platform was implemented in a rural District in the Northern Province.
View Article and Find Full Text PDFJ Health Popul Nutr
April 2018
Epidemiology and Global Health Unit, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Background: Despite the widespread use of antenatal care (ANC), its effectiveness in low-resource settings remains unclear. In this study, self-reported health-related quality of life (HRQoL) was used as an alternative to other maternal health measures previously used to measure the effectiveness of antenatal care. The main objective of this study was to determine whether adequate antenatal care utilization is positively associated with women's HRQoL.
View Article and Find Full Text PDF